Subcutaneous device for monitoring and/or providing therapies
AssigneeManicka Institute LLC
InventorYatheendhar D. Manicka
Life of this patent
Estimating the term…
Abstract
A subcutaneously implantable device includes a housing, a clip attached to a top side of the housing, a first prong with a proximal end attached to the housing and a distal end extending away from the housing, and a first electrode on the first prong. The clip is configured to anchor the device to a muscle, a bone, and/or a tissue. The first prong is configured to contact a heart. The first electrode is configured to contact the heart. Sensing circuitry in the housing that is configured to sense an electrical signal from the heart, and therapeutic circuitry in the housing is in electrical communication with the first electrode and is configured to deliver electrical stimulation to the heart through the first electrode.
Claims17
A subcutaneously implantable device comprising:
- a housing;
- a clip attached to a top side of the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue;
- a drug pump and a drug reservoir in the housing, wherein the drug pump is fluidly connected to the drug reservoir with a first fluid connector;
- a first prong with a lumen extending through the first prong and having a proximal end attached to the housing and the drug pump, and a distal end extending away from the housing that is configured to contact an organ, a nerve, and/or a second tissue, wherein the first prong is fluidly connected to the drug pump with a second fluid connector;
- circuitry in the housing in electrical communication with the drug pump that is configured to deliver a signal to the drug pump to provide a targeted or systemic therapeutic drug to the organ, the nerve, and/or the second tissue through the lumen running through the first prong;
- and
- a battery in the housing that is configured to power the circuitry and the drug pump.
A subcutaneously implantable device comprising:
- a housing;
- a clip attached to a top side of the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue;
- a drug pump and a drug reservoir in the housing, wherein the drug pump is fluidly connected to the drug reservoir with a first fluid connector;
- a first prong with a lumen extending through the first prong and having a proximal end attached to the housing and the drug pump, and a distal end extending away from the housing that is configured to contact an organ, a nerve, and/or a second tissue, wherein the first prong is fluidly connected to the drug pump with a second fluid connector;
- a second prong with a lumen extending through the second prong and having a proximal end attached to the housing and the drug reservoir, and a distal end extending away from the housing, wherein the second prong is fluidly connected to the drug reservoir with a third fluid connector;
- circuitry in the housing in electrical communication with the drug pump that is configured to deliver a signal to the drug pump to provide a targeted or systemic therapeutic drug to the organ, the nerve, and/or the second tissue through the lumen running through the first prong;
- and
- a battery in the housing that is configured to power the circuitry and the drug pump.
Dependencies are inferred from the claim text.